Novo Nordisk to present data from STEP UP trial on a higher dose of Wegovy® (semaglutide 7.2 mg) for those in need of greater weight loss Data will expand semaglutide evidence in both a clinical ...

Retrospective real-world analyses of patients with type 2 diabetes—some of whom also had chronic kidney disease—demonstrate cardiac arrhythmias present frequent and early, often preceding major ...

Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people with overweight or obesity was published in The Lancet and presented at the American Diabetes ...

Bagsværd, Denmark, 20 June 2025 – Novo Nordisk announces subcutaneous amycretin data being presented at the American Diabetes Association (ADA) 85 th Scientific Sessions in Chicago, US. 1 Full ...

Bagsværd, Denmark, 10 June – Novo Nordisk today announced that new data from its industry-leading portfolio in metabolic and cardiovascular health will be showcased at the upcoming American Diabetes ...

THE Department of Agriculture (DA) has revived its livestock data group to stabilize the country’s meat supply. Agriculture Secretary Francisco Tiu Laurel Jr. signed Special Order 599, which ...

XRP, Cardano (ADA), and Solana (SOL) tokens are exhibiting technical strength in a signal of potential short-term price recoveries, data indicates.

Cardano (ADA) ‘bottomed’ and on verge of ‘grand bull market’ — Peter Brandt ADA looks ready to chase new all-time highs, according to a handful of Cardano price metrics.

Posts falsely claim “60 Minutes” warned Facebook would begin using people’s data unless a message is shared. No chain message can stop Facebook from using your data.

Truist analyst Joon Lee keeps a Buy rating and $150 price target on Axsome Therapeutics (AXSM) while noting that the firm is an "aggressive buyer" of the stock after the "positive" Phase 3 results ...

Orzales said one major hurdle in the industry is the lack of reliable data on milkfish production and trade, saying this complicates planning and policymaking. During a recently concluded dialogue ...